United Kingdom · Question · Written question
UIN 85688
Psilocybin: Clinical Trials
Original
Introduced
28 October 2025
Last action
3 November 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
3 November 2025
Summary
To ask the Secretary of State for Health and Social Care, whether he has received evidence on the potential clinical use of psilocybin under controlled conditions to treat serious psychiatric illness; whether his Department has made an assessment of the p
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
28 October 2025
Written question
To ask the Secretary of State for Health and Social Care, whether he has received evidence on the potential clinical use of psilocybin under controlled conditions to treat serious psychiatric illness; whether his Department has made an assessment of the p
Source: Commons
3 November 2025
Answer
The Medicines and Healthcare Products Regulatory Agency (MHRA) is an executive agency of the Department and regulates medicine, medical devices, and blood components for transfusion in the United Kingdom, with responsibility for ensuring medicines meet ap...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-10-28/85688
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1846015
- uk · wq-1846015 · source updated 3 November 2025